Nucleotide substitution: T9922C. Amino acid replacement: A107V.
C10533366T
C9922T
A107V | lola-PA; A107V | lola-PAA; A107V | lola-PB; A107V | lola-PC; A107V | lola-PD; A107V | lola-PE; A107V | lola-PF; A107V | lola-PG; A107V | lola-PH; A107V | lola-PI; A107V | lola-PJ; A107V | lola-PK; A107V | lola-PL; A107V | lola-PM; A107V | lola-PO; A107V | lola-PP; A107V | lola-PQ; A107V | lola-PR; A107V | lola-PT; A107V | lola-PU; A107V | lola-PV; A107V | lola-PW; A107V | lola-PX; A107V | lola-PY; A107V | lola-PZ
A107V
Females containing homozygous germline clones show defects in stage 14 egg chambers, including dumpless egg chambers (egg chambers in which the nurse cells have failed to transfer their cytoplasmic contents to the oocyte, have intact nuclei and do not appear to be undergoing programmed cell death) and egg chambers with persisting nurse cell nuclei (egg chambers in which nurse cells have transferred their cytoplasmic contents to the oocyte, but their nuclei have failed to undergo programmed cell death including nuclear condensation).
Fas2-expressing axons cross the midline in only 25% of homozygous stage 16/17 embryos, with one or two segments per embryo usually being affected.
lolaORE120 has abnormal neuroanatomy phenotype, enhanceable by robo[+]/robo13
lolaORE120 has abnormal neuroanatomy phenotype, enhanceable by sli2/sli[+]
lolaORE120 has larval longitudinal connective phenotype, enhanceable by robo[+]/robo13
lolaORE120 has larval longitudinal connective phenotype, enhanceable by sli2/sli[+]
lolaORE120/lola[+] is an enhancer of wing margin phenotype of ct53d
98% of lolaORE120 sli2/lolaORE120 embryos show Fas2-expressing axons crossing the midline. There are an average of 4.8 crossovers per affected embryo. 93% of lolaORE120 robo3/lolaORE120 embryos show Fas2-expressing axons crossing the midline. There are an average of 4.4 crossovers per affected embryo.